New uses for new and old quinolones and the challenge of resistance
- PMID: 10671323
- DOI: 10.1086/313677
New uses for new and old quinolones and the challenge of resistance
Comment in
-
Reassuring safety profile of moxifloxacin.Clin Infect Dis. 2001 Apr 1;32(7):1112-4. doi: 10.1086/319615. Clin Infect Dis. 2001. PMID: 11264046 No abstract available.
Similar articles
-
The fluoroquinolones after ciprofloxacin and ofloxacin.Curr Clin Top Infect Dis. 2000;20:63-91. Curr Clin Top Infect Dis. 2000. PMID: 10943519 Review. No abstract available.
-
The role of the fluoroquinolones in primary care practice.Clin Invest Med. 1989 Feb;12(1):71-3. Clin Invest Med. 1989. PMID: 2920484 No abstract available.
-
Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.Clin Pharm. 1993 Jun;12(6):452-8. Clin Pharm. 1993. PMID: 8403817 No abstract available.
-
Two new fluoroquinolones.Med Lett Drugs Ther. 1992 Jun 12;34(872):58-60. Med Lett Drugs Ther. 1992. PMID: 1317502 No abstract available.
-
The role of the fluoroquinolones.Pharmacotherapy. 1992;12(6 Pt 2):71S-85S. Pharmacotherapy. 1992. PMID: 1480503 Review.
Cited by
-
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2002 May;46(5):1503-9. doi: 10.1128/AAC.46.5.1503-1509.2002. Antimicrob Agents Chemother. 2002. PMID: 11959588 Free PMC article.
-
N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.Daru. 2018 Dec;26(2):199-207. doi: 10.1007/s40199-018-0226-0. Epub 2018 Nov 3. Daru. 2018. PMID: 30392156 Free PMC article.
-
Design and Synthesis of Thionated Levofloxacin: Insights into a New Generation of Quinolones with Potential Therapeutic and Analytical Applications.Curr Issues Mol Biol. 2022 Oct 3;44(10):4626-4638. doi: 10.3390/cimb44100316. Curr Issues Mol Biol. 2022. PMID: 36286031 Free PMC article.
-
Multiplex Real-Time Polymerase Chain Reaction-Based Method for the Rapid Detection of gyrA and parC Mutations in Quinolone-Resistant Escherichia coli and Shigella spp.Osong Public Health Res Perspect. 2012 Jun;3(2):113-7. doi: 10.1016/j.phrp.2012.04.004. Osong Public Health Res Perspect. 2012. PMID: 24159500 Free PMC article.
-
In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.Antimicrob Agents Chemother. 2001 Dec;45(12):3616-22. doi: 10.1128/AAC.45.12.3616-3622.2001. Antimicrob Agents Chemother. 2001. PMID: 11709353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical